Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2018 (2018), Article ID 4239646, 10 pages
https://doi.org/10.1155/2018/4239646
Review Article

Hepatitis B Virus Infection in Tanzania: Current Status and Challenges

1Department of Internal Medicine, Catholic University of Allied and Health Sciences, P. O. Box 1440, Mwanza, Tanzania
2Department of Internal Medicine, Bugando Medical Centre, P.O. Box 1370, Mwanza, Tanzania
3Department of Medicine, College of Health Sciences, University of Dodoma, P. O. Box 395, Dodoma, Tanzania
4Renal Unit, Department of Internal Medicine, The Aga Khan Hospital, P.O. Box 2289, Dar es Salaam, Tanzania

Correspondence should be addressed to Semvua B. Kilonzo; moc.oohay@bcpikes

Received 1 November 2017; Revised 18 December 2017; Accepted 3 January 2018; Published 30 January 2018

Academic Editor: Marcel Tanner

Copyright © 2018 Semvua B. Kilonzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection, Geneva, Switzerland, 2015.
  2. C.-L. Lin and J.-H. Kao, “The clinical implications of hepatitis B virus genotype: recent advances,” Journal of Gastroenterology and Hepatology, vol. 26, supplement 1, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Busch and R. Thimme, “Natural history of chronic hepatitis B virus infection,” Medical Microbiology and Immunology, vol. 204, no. 1, pp. 5–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. CDC, “Interpretation of Hepatitis B Serologic Test Results 2017,” https://www.cdc.gov/hepatitis/HBV/PDFs/SerologicChartv8.pdf.
  5. World Health Organization, “Global Hepatitis Report,” Tech. Rep., 2017. View at Google Scholar
  6. A. Schweitzer, J. Horn, R. T. Mikolajczyk, G. Krause, and J. J. Ott, “Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013,” The Lancet, vol. 386, no. 10003, pp. 1546–1555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. W. C. Miller, J. F. Shao, D. J. Weaver, G. H. Shimokura, D. A. Paul, and G. J. Lallinger, “Seroprevalence of viral hepatitis in Tanzanian adults,” Tropical Medicine & International Health, vol. 3, no. 9, pp. 757–763, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Pellizzer, C. Blé, N. Zarnperetti et al., “Serological survey of hepatitis B infection in Tanzania,” Public Health, vol. 108, no. 6, pp. 427–431, 1994. View at Publisher · View at Google Scholar
  9. F. J. Muro, S. P. Fiorillo, P. Sakasaka et al., “Seroprevalence of hepatitis B and C viruses among children in Kilimanjaro Region, Tanzania,” Journal of the Pediatric Infectious Diseases Society, vol. 2, no. 4, Article ID pit018, pp. 320–326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Meschi, M. Sañé Schepisi, E. Nicastri et al., “The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania,” Journal of Medical Virology, vol. 82, no. 9, pp. 1569–1575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Ministry of health and social welfare, “Tanzania Mainland EPI Review 2010,” Dar es Salaam, Tanzania.
  12. UNICEF, “United Republic of Tanzania: WHO and UNICEF estimates of immunization coverage: 2015 revision,” Dar es Salaam, Tanzania.
  13. J. C. Forbi, M. Dillon, M. A. Purdy et al., “Molecular epidemiology of hepatitis B virus infection in Tanzania,” Journal of General Virology, vol. 98, no. 5, Article ID 000776, pp. 1048–1057, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Hasegawa, Y. Tanaka, F. Kurbanov et al., “Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania,” Journal of Medical Virology, vol. 78, no. 8, pp. 1035–1042, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Kew, A. Kramvis, M. C. Yu, K. Arakawa, and J. Hodkinson, “Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans,” Journal of Medical Virology, vol. 75, no. 4, pp. 513–521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Jaka, S. E. Mshana, P. F. Rambau, N. Masalu, P. L. Chalya, and S. E. Kalluvya, “Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting,” World Journal of Surgical Oncology, vol. 12, article 246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Ministry of Health Community Development Gender Elderly and Children, Tanzania’s Blood services: Fact Sheet 2017. National Blood Transfusion Service Blood Collection Report: January to December 2016, 2017, Dar es Salaam, Tanzania.
  18. M. I. N. Matee, P. M. Magesa, and E. F. Lyamuya, “Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania,” BMC Public Health, vol. 6, article no. 21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. J. Liu and J. H. Kao, “Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J,” Seminars in Liver Disease, vol. 33, no. 2, pp. 97–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Jacobs, P. Mayaud, J. Changalucha et al., “Sexual transmission of hepatitis B in Mwanza, Tanzania,” Sexually Transmitted Diseases, vol. 24, no. 3, pp. 121–126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. S. A. Al-Busafi, “Do we have guidelines for the prevention of Hepatitis B virus perinatal transmission?” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 53, no. 5, pp. 506–506, 2013. View at Publisher · View at Google Scholar
  22. W.-H. Wen, M.-H. Chang, L.-L. Zhao et al., “Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention,” Journal of Hepatology, vol. 59, no. 1, pp. 24–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. D. Burk, L.-Y. Hwang, G. Y. F. Ho, D. A. Shafritz, and R. P. Beasley, “Outcome of perinatal hepatitis b virus exposure is dependent on maternal virus load,” The Journal of Infectious Diseases, vol. 170, no. 6, pp. 1418–1423, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Manyahi, Y. Msigwa, F. Mhimbira, and M. Majigo, “High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: A cross sectional study,” BMC Pregnancy and Childbirth, vol. 17, no. 1, article no. 109, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Msuya, E. Mbizvo, A. Hussain, N. Sam, and B. Stray-Pedersen, “Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi urban, Tanzania,” East African Medical Journal, vol. 83, no. 2, 2006. View at Publisher · View at Google Scholar
  26. M. M. Mirambo, P. B. Mbena, M. F. Mushi, M. Mtebe, J. Seni, and S. E. Mshana, “Prevalence of hepatitis b surface antigen among pregnant women attending antenatal clinic at nyamagana district hospital mwanza, tanzania,” Tanzania Journal of Health Research, vol. 18, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. S. Ciorlia and D. M. T. Zanetta, “Hepatitis B in healthcare workers: prevalence, vaccination and relation to occupational factors,” The Brazilian Journal of Infectious Diseases, vol. 9, no. 5, pp. 384–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. Lewis, K. B. Enfield, and C. D. Sifri, “Hepatitis B in healthcare workers: Transmission events and guidance for management,” World Journal of Hepatology, vol. 7, no. 3, pp. 488–497, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Mueller, L. Stoetter, S. Kalluvya et al., “Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania,” BMC Infectious Diseases, vol. 15, no. 1, article no. 386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. P. L. Chalya, J. Seni, and M. F. Mushi, “Needle-stick injuries and splash exposures among health-care workers at a tertiary care hospital in north-western Tanzania,” Tanzan. J. Health Res, vol. 17, no. 2, 2015. View at Google Scholar
  31. M. Lahuerta, D. Selenic, G. Kassa et al., “Reporting and case management of occupational exposures to blood-borne pathogens among healthcare workers in three healthcare facilities in Tanzania,” Journal of Infection Prevention, vol. 17, no. 4, pp. 153–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Mabwe, A. T. Kessy, and I. Semali, “Understanding the magnitude of occupational exposure to human immunodeficiency virus (HIV) and uptake of HIV post-exposure prophylaxis among healthcare workers in a rural district in Tanzania,” Journal of Hospital Infection, vol. 96, no. 3, pp. 276–280, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Gumodoka, L. Favot, Z. A. Berege, and W. M. V. Dolmans, “Occupational exposure to the risk of HIV infection among health care workers in Mwanza Region, United Republic of Tanzania,” Bulletin of the World Health Organization, vol. 75, no. 2, pp. 133–140, 1997. View at Google Scholar · View at Scopus
  34. K. O. Mashoto, G. M. Mubyazi, E. Makundi, H. Mohamed, and H. M. Malebo, “Estimated risk of HIV acquisition and practice for preventing occupational exposure: A study of healthcare workers at Tumbi and Dodoma Hospitals, Tanzania,” BMC Health Services Research, vol. 13, no. 1, article no. 369, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Debes, J. Kayandabila, and H. Pogemiller, “Knowledge of hepatitis B transmission risks among health workers in Tanzania,” The American Journal of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 1100–1102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Edey, K. Barraclough, and D. W. Johnson, “Review article: Hepatitis B and dialysis,” Nephrology, vol. 15, no. 2, pp. 137–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. J. Meremo, D. P. Ngilangwa, M. Y. Mwashambwa et al., “Challenges and outcomes of haemodialysis among patients presenting with kidney diseases in Dodoma, Tanzania,” BMC Nephrology, vol. 18, no. 1, article no. 212, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. M. I. Matee, E. F. Lyamuya, and E. C. Mbena, “Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam,” East Afr. Med. J, vol. 76, no. 3, pp. 167–71, 1999. View at Google Scholar
  39. S. Rashid, C. Kilewo, and S. Aboud, “Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es Salaam, Tanzania,” Tanzania Journal of Health Research, vol. 1, no. 16, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Mohammed and A. A Salim, “HIV ans Substance abuse: The Dual Epidemics Challenging Zanzibar,” African J. Drug Alcohol Stud, vol. 5, no. 2, p. 128, 2006. View at Google Scholar
  41. S. B. Kilonzo, D. W. Gunda, F. Kashasha, and B. C. Mpondo, “Liver fibrosis and Hepatitis B coinfection among ART Naive HIV-infected patients at a tertiary level hospital in Northwestern Tanzania: A cross-sectional study,” Journal of Tropical Medicine, vol. 2017, Article ID 5629130, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ramírez-Mena, T. R. Glass, A. Winter et al., “Prevalence and outcomes of Hepatitis B coinfection and associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a rural Tanzanian human immunodeficiency virus Cohort,” Open Forum Infectious Diseases, vol. 3, no. 3, p. ofw162, 2016. View at Publisher · View at Google Scholar
  43. C. Hawkins, B. Christian, J. Ye et al., “Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania,” AIDS, vol. 27, no. 6, pp. 919–927, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. S. P. Telatela, M. I. Matee, and E. K. Munubhi, “Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania,” BMC Public Health, vol. 7, article no. 338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Mohamed, J. Mbwambo, Y. Shimakawa et al., “Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania,” Journal of the International AIDS Society, vol. 20, no. 1, p. 21856, 2017. View at Publisher · View at Google Scholar
  46. T. J. Nagu, M. Bakari, and M. Matee, “Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania,” BMC Public Health, vol. 8, article no. 416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-J. Chu and S.-D. Lee, “Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment,” Journal of Gastroenterology and Hepatology, vol. 23, no. 4, pp. 512–520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. E. Barth, Q. Huijgen, J. Taljaard, and A. I. M. Hoepelman, “Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis,” International Journal of Infectious Diseases, vol. 14, no. 12, pp. e1024–e1031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Hawkins, B. Christian, E. Fabian et al., “HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults,” Journal of Acquired Immune Deficiency Syndromes, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. E. C. Thomson, V. M. Fleming, J. Main et al., “Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men,” Gut, vol. 60, no. 6, pp. 837–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. United Nations Office on Drugs and Crime, “World Drug Report 2015,” Vienna, Austria.
  52. A. L. Bowring, N. Luhmann, S. Pont et al., “An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011,” International Journal of Drug Policy, vol. 24, no. 1, pp. 78–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Kitundu, A. Msengi, M. Matee et al., “Post-transfusion hepatitis C seroprevalence in Tanzanian children,” Annals of Tropical Paediatrics, vol. 21, no. 4, pp. 343–348, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Potthoff, H. Wedemeyer, W. O. Boecher et al., “The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection,” Journal of Hepatology, vol. 49, no. 5, pp. 688–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. World Health Organization, Guidance on prevention of viral hepatitis B and C among people who inject drugs, Geneva, Switzerland, 2012.
  56. N. Debaulieu and N. Luhmann, “Starting comprehensive harm reduction in Temeke District, Dar-es-Salaam, Tanzania,” in in Paper presented at the International Harm Reduction Association Conference, Dar-es-Salaam, Tanzania, 2011.
  57. A. Winter, E. Letang, A. Vedastus Kalinjuma et al., “Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania,” International Journal of Infectious Diseases, vol. 46, pp. 8–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Muchiri, F. A. Okoth, J. Ngaira, and S. Tuei, “Seroprevalence OF HAV, HBV, HCV, AND HEV among acute hepatitis patients at kenyatta national hospital in Nairobi, Kenya,” East African Medical Journal, vol. 89, no. 6, pp. 199–205, 2012. View at Google Scholar · View at Scopus
  59. G. B. Gerbi, R. Williams, B. Bakamutumaho et al., “Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010-2012,” The American Journal of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 411–414, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. R. L. Hamers, H. L. Zaaijer, C. L. Wallis et al., “HIV-HBV coinfection in Southern Africa and the effect of Lamivudine- Versus tenofovir-containing cART on HBV outcomes,” Journal of Acquired Immune Deficiency Syndromes, vol. 64, no. 2, pp. 174–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Stewart, M. L. Jobarteh, R. Sarge-Njie et al., “Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, West Africa,” BMC Research Notes, vol. 4, article no. 561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. K. MR, “Reproductive Tract Infections among Female Sex Workers in Dar es Salaam, Tanzania,” Journal of HIV and AIDS, vol. 2, no. 4, 2016. View at Publisher · View at Google Scholar
  63. S. K. Sarin, M. Kumar, G. K. Lau et al., “Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update,” Hepatology International, vol. 10, no. 1, pp. 1–98, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Metodi, S. Aboud, R. Mpembeni, and E. Munubhi, “Immunity to hepatitis B vaccine in Tanzanian under-5 children,” Annals of Tropical Paediatrics, vol. 30, no. 2, pp. 129–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Pippi, L. Bracciale, L. Stolzuoli et al., “Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania,” HIV Medicine, vol. 9, no. 7, pp. 519–525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. European Association for the Study of the Liver, “EASL clinical practice guidelines: management of chronic hepatitis B virus infection,” Journal of Hepatology, vol. 57, no. 1, pp. 167–185, 2013. View at Publisher · View at Google Scholar
  67. N. A. Terrault, N. H. Bzowej, K.-M. Chang, J. P. Hwang, M. M. Jonas, and M. H. Murad, “AASLD guidelines for treatment of chronic hepatitis B,” Hepatology, vol. 63, no. 1, pp. 261–283, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Han, H.-W. Zhang, J.-X. Xie, Q. Zhang, H.-Y. Wang, and G.-W. Cao, “A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus,” World Journal of Gastroenterology, vol. 17, no. 38, pp. 4321–4333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. World Health Organization, “Global health sector strategy on viral hepatitis 2016–2021,” 2016.
  70. H. Zhang, C. Q. Pan, Q. Pang, R. Tian, M. Yan, and X. Liu, “Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice,” Hepatology, vol. 60, no. 2, pp. 468–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. V. Sundaram and K. Kowdley, “Management of chronic hepatitis B infection,” BMJ, vol. 351, Article ID h4263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. Gastroenterology Society of Kenya, “Guidelines for the Treatment of Chronic Hepatitis B and C Viral Infections in Kenya”.
  73. C. W. Spearman, M. W. Sonderup, J. F. Botha et al., “South African guideline for the management of chronic hepatitis B: 2013,” South African Medical Journal, vol. 103, no. 5, p. 335, 2013. View at Publisher · View at Google Scholar
  74. S. Jayaraman, Z. Chalabi, P. Perel, C. Guerriero, and I. Roberts, “The risk of transfusion-transmitted infections in sub-Saharan Africa,” Transfusion, vol. 50, no. 2, pp. 433–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. World Health Organization, Blood safety, 2002.
  76. D. Mosha, A. Poulsen, H. Reyburn, E. Kituma, F. Mtei, and I. C. Bygbjerg, “Quality of paediatric blood transfusions in two district hospitals in Tanzania: A cross-sectional hospital based study,” BMC Pediatrics, vol. 9, article no. 51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Drammeh, A. De, N. Bock et al., “Estimating Tanzania's National Met and Unmet Blood Demand From a Survey of a Representative Sample of Hospitals,” Transfusion Medicine Reviews, 2017. View at Publisher · View at Google Scholar · View at Scopus
  78. S. B. Ng`weng`weta and D. S. Tarimo, “Urinary schistosomiasis among preschool-age children in an endemic area of Kinondoni municipality, Dar es Salaam, Tanzania 2016,” Asian Pacific Journal of Tropical Disease, vol. 7, no. 3, pp. 162–168, 2017. View at Publisher · View at Google Scholar
  79. J. Nilsson, A. B. Pembe, M. Urasa, and E. Darj, “Safe injections and waste management among healthcare workers at a regional hospital in northern Tanzania,” Tanzania Journal of Health Research, vol. 15, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. E. M. Veilla and V. M. Samwel, “Assessment of sharps waste management practices in a referral hospital,” African Journal of Environmental Science and Technology, vol. 10, no. 3, pp. 86–95, 2016. View at Publisher · View at Google Scholar
  81. K. Kuchibanda and A. W. Mayo, “Public health risks from mismanagement of healthcare wastes in Shinyanga municipality health facilities, Tanzania,” The Scientific World Journal, vol. 2015, Article ID 981756, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. S. V. Manyele and C. M. Mujuni, “Current status of sharps waste management in the lower-level health facilities in Tanzania,” Tanzania Journal of Health Research, vol. 12, no. 4, pp. 1–10, 2010. View at Google Scholar · View at Scopus
  83. R. G. Nachilongo and A. Hellen, “Alarm as hepatitis cases on the rise in TZ,” The Citizen, 2017. View at Google Scholar
  84. N. John, “Muhimbili to launch 5-year hepatitis B treatment plan,” The Citizen, 2016. View at Google Scholar
  85. World Health Organization, “Eliminate Hepatitis:WHO 2017,” http://www.who.int/hepatitis/news-events/infographic.png?ua=1.